Bacillus coagulans and application thereof in treatment of alcoholic liver disease
A technology for Bacillus coagulans and alcoholic liver disease, applied in the field of microorganisms, can solve problems such as Bacillus coagulans alcoholic liver disease, and achieve the effects of reducing lipid accumulation, repairing liver tissue, and repairing intestinal barrier
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] Isolation, Identification and Preservation of Example 1 Bacterial Strains
[0055] 1. Isolation of strains
[0056] Samples were collected from a cattle farm in Xinkai Village, Mianzhu City, Deyang City, Sichuan Province. The samples taken were fresh cow feces.
[0057] The samples were streaked repeatedly on the solid YPD medium plate, and the single colony that produced the yellow circle was picked and inoculated on the solid YPD medium plate to continue the culture, and then repeatedly streaked and purified on the solid YPD medium plate to obtain multiple pure culture strains .
[0058] Gram-positive strains were screened from purely cultured strains and inoculated into liquid YPD medium for culture, then added 20% glycerol, and stored in a -80°C refrigerator.
[0059] 2. Identification of strains
[0060] Morphological identification, physiological and biochemical identification and molecular identification were performed on the isolated strains, and the strain F...
Embodiment 2
[0068] Example 2 Therapeutic Effect of Bacillus coagulans FCYS01 on Alcoholic Liver Disease Mice
[0069] 1. Preparation of bacterial suspension
[0070] The preparation method of the bacterial suspension: suspend the tested bacteria with PBS buffer, so that the bacterial concentration is 1.0×10 9 CFU / 200 μL.
[0071] The test bacteria is Bacillus coagulans FCYS01, and the obtained bacterial suspension is named as FCYS01 bacterial suspension.
[0072] Two, group processing
[0073] 45 male C57 mice were randomly divided into 3 groups, 15 in each group, and the grouping was handled as follows:
[0074] Blank group: from the beginning to the end of the test, the Lieber-DeCarli basic control liquid feed was used to feed; from the 8th day of the test to the 15th day, sterile PBS buffer solution was given (administration method: gavage, dosage: 200ul / per only / every day); on the 16th day, give 45% (w / v) dextrin solution (administration mode: gavage, administration amount: the vo...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


